期刊
CURRENT OPINION IN BIOTECHNOLOGY
卷 23, 期 5, 页码 644-650出版社
ELSEVIER SCI LTD
DOI: 10.1016/j.copbio.2012.01.013
关键词
-
资金
- German Research Foundation [SPP1230-Ca311/2, SFB738-C9]
- Federal Ministry of Education and Research [InTherGD-01GU0834, ReGene-01GN1003B]
- European Commission [PERSIST-222878, HeMiBio-266777]
- Mukoviszidose Institut gGmbH [S03/11]
Custom-made designer nucleases have evolved into an indispensable platform to precisely alter complex genomes for basic research, biotechnology, synthetic biology, or human gene therapy. In this review we describe how transcription activator-like effector nucleases (TALENs) have rapidly developed into a chief technology for targeted genome editing in different model organisms as well as human stem cells. We summarize the technological background and provide an overview of the current state-of-the-art of TALENs with regard to activity and specificity of these nucleases for targeted genome engineering.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据